Literature DB >> 35920987

An umbrella review of systematic reviews with meta-analysis on the role of vitamins in Parkinson's disease.

Sama Rahnemayan1,2, Sasan Ghazanfar Ahari1, Reza Rikhtegar3, Sevda Riyahifar4, Sarvin Sanaie5.   

Abstract

INTRODUCTION: This umbrella review aimed to systematically review the available literature and assess the association of dietary intake or serum levels of different vitamins and the risk of PD, to help find out more efficient treatments for PD patients by replenishing the deficiency of vitamins.
METHODS: Pubmed/Medline, Scopus, Google Scholar and hand searching bibliographies of retrieved articles in duplicate, were used to detect all relevant meta-analyses investigating the relationship between vitamins and PD. After study selection, data were extracted from previously published meta-analyses and pooled by Review Manager version 5.4 and CMA software version 2.2.064 to achieve effect sizes. Level of statistical significance was set at P ≤ 0.05.
RESULTS: 14 meta-analyses were included in the meta-review. Serum vitamin D and B12 levels were significantly lower in PD (SMD = -0.67 and SMD = -0.40 respectively). Homocysteine (Hcy) levels were significantly higher in PD patients (SMD = 1.26). Also the odds ratio for highest vs. lowest vitamin E intake was 0.73 which was significant. However, there was no significant difference between vitamin A, C and B6 intake or serum levels in PD vs. control groups.
CONCLUSION: Serum vitamin D and B12 levels were significantly lower in PD in comparison to healthy individuals, while Hcy level was significantly higher in PD patients. Also higher vitamin E intake was associated with significantly lower risk of development of PD in comparison to lower vitamin E intake. However, there was no significant difference between risk of PD and higher vitamin A, C and B6 intake or serum levels of folate.
© 2022. The Author(s) under exclusive licence to Belgian Neurological Society.

Entities:  

Keywords:  Antioxidants; Parkinson’s disease; Vitamins

Year:  2022        PMID: 35920987     DOI: 10.1007/s13760-022-02055-3

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.471


  57 in total

1.  Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.

Authors:  Cory Toth; Kim Breithaupt; Shaohua Ge; Yanjun Duan; Joan M Terris; Anita Thiessen; Samuel Wiebe; Douglas W Zochodne; Oksana Suchowersky
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

2.  Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis.

Authors:  Mahyar Etminan; Sudeep S Gill; Ali Samii
Journal:  Lancet Neurol       Date:  2005-06       Impact factor: 44.182

Review 3.  Vitamin A and carotenoids and the risk of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Andrea Takeda; Olga P Nyssen; Asmat Syed; Eugene Jansen; Bas Bueno-de-Mesquita; Valentina Gallo
Journal:  Neuroepidemiology       Date:  2013-12-12       Impact factor: 3.282

4.  Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.

Authors:  Yi Xie; Hongliang Feng; Sisi Peng; Jinsong Xiao; Junjian Zhang
Journal:  Neurosci Lett       Date:  2016-11-10       Impact factor: 3.046

5.  Parkinson's disease: etiopathogenesis and treatment.

Authors:  Joseph Jankovic; Eng King Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-06-23       Impact factor: 10.154

Review 6.  Homocysteine and cognition: A systematic review of 111 studies.

Authors:  Esther Setién-Suero; Marta Suárez-Pinilla; Paula Suárez-Pinilla; Benedicto Crespo-Facorro; Rosa Ayesa-Arriola
Journal:  Neurosci Biobehav Rev       Date:  2016-08-13       Impact factor: 8.989

Review 7.  Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis.

Authors:  Bao Dong; Rongrong Wu
Journal:  Clin Neurol Neurosurg       Date:  2019-11-04       Impact factor: 1.876

Review 8.  Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management.

Authors:  Antonino Uncini; Roberto Eleopra; Marco Onofrj
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-28       Impact factor: 10.154

Review 9.  Benefits of Vitamins in the Treatment of Parkinson's Disease.

Authors:  Xiuzhen Zhao; Ming Zhang; Chunxiao Li; Xue Jiang; Yana Su; Ying Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-02-20       Impact factor: 6.543

Review 10.  Associations between B Vitamins and Parkinson's Disease.

Authors:  Liang Shen
Journal:  Nutrients       Date:  2015-08-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.